Turn Therapeutics Inc.
NASDAQ:TTRXBiotechnology
-$0.17 today
- Market cap
- $271.79M
- Beta
- 2.77
- P/E (TTM)
- -45.0
- EPS (TTM)
- -$0.13
Volume 0.05M
Average 0.04M
TTRX Account Payables
Amounts the company owes suppliers for goods and services received.
Turn Therapeutics Inc.NASDAQ: TTRX
Account Payables · Q1 FY2026 · quarter ended Mar 2026
Account payables of $2.32M in Q1 FY2026
Q1 FY2026 account payables was $2.32M.
Context
- Account payables amounted to 12.4% of total assets at the end of Q1 FY2026.
- Account payables increased in 1 of the last 2 fiscal years.
- FY2025 was the highest annual figure in the 3 fiscal years shown.
Sources:Balance SheetText generated from reported figures; not investment advice.
Account Payables history
USD · from the balance sheet
- Latest · FY2025
- 2.93M USD
- Year-over-year change
- —
| Period | Period end | Account Payables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 2.93M | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
Account Payables vs competitors
How TTRX compares with its peers on the latest reported figures
- TTRX's Mar 2026 account payables of $2.32M is the 7th highest of the 9 companies compared; the peer median is $3.9M.
- Account payables amounts to 12.4% of total assets for TTRX, versus a peer median of 8.6%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $71.08M | +10.7% | +26.6% | 38.1% | |
| Mar 2026 | $4.51M | +445.2% | — | 42.9% | |
IRDOpus Genetics, Inc. | Mar 2026 | $4.42M | +82.0% | +45.5% | 6.6% |
| Mar 2026 | $3.95M | +28.2% | +25.3% | 13.3% | |
| Mar 2026 | $3.85M | +111.4% | -29.7% | 10.7% | |
| Mar 2026 | $2.5M | -43.9% | +38.7% | 0.9% | |
TTRXTurn Therapeutics Inc. | Mar 2026 | $2.32M | — | — | 12.4% |
| Mar 2026 | $1.59M | -6.2% | +0.2% | 0.9% | |
| Apr 2026 | $252K | -11.3% | -14.6% | 1.7% | |
| Peer median (excluding TTRX) | $3.9M | +19.4% | +25.3% | 8.6% | |
Competitors are the stored peer set for TTRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Turn Therapeutics Inc.
NASDAQ:TTRX
Intrinsic Alpha fair value
Locked
Current Price
$8.89
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.